Old Web
English
Sign In
Acemap
>
authorDetail
>
Jim Chan
Jim Chan
Kaiser Permanente
Medicine
Retrospective cohort study
Internal medicine
Medical record
Clinical trial
4
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use of immune checkpoint inhibitors in a community practice within a vertically integrated health care system.
2018
Journal of Clinical Oncology
Robert Michael Cooper
Christopher Yamamoto
Thach-Giao Truong
Fang Niu
Helen Moon
Michele M. Spence
Jim Chan
Timothy Chiu
Rita L. Hui
Show All
Source
Cite
Save
Citations (0)
Immune-related adverse events (IrAE) of elderly patients (pts) receiving PD-1 or PDL-1 inhibitors (PDIs) in a community-oncology setting: The experience at Kaiser Permanente California.
2018
Journal of Clinical Oncology
Thach-Giao Truong
Christopher Yamamoto
Timothy Chiu
Fang Niu
Michele M. Spence
Jim Chan
Robert Michael Cooper
Helen Moon
Rita L. Hui
Show All
Source
Cite
Save
Citations (2)
Evaluation of the role of UGT1A1 genotype testing in colorectal cancer patients administered irinotecan and the occurence of grade 3 and 4 neutropenia.
2012
Journal of Clinical Oncology
Sushma M. Patel
Jim Chan
Rita L. Hui
Michele M. Spence
Show All
Source
Cite
Save
Citations (1)
Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses†
2007
Pharmacoepidemiology and Drug Safety
Nina Oestreicher
Gary D. Friedman
Sheng-Fang Jiang
Jim Chan
Charles P. Quesenberry
Laurel A. Habel
Show All
Source
Cite
Save
Citations (14)
1